Tectonic Therapeutic, Inc.
TECX
$21.09
-$1.29-5.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -57.24% | -76.22% | -21.20% | -5.37% | 23.54% |
| Total Depreciation and Amortization | 36.19% | 14.29% | -9.19% | 3.57% | 15.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 258.44% | 252.16% | 305.62% | 389.98% | -175.74% |
| Change in Net Operating Assets | -49.36% | -760.84% | -1,585.13% | 6.04% | -329.34% |
| Cash from Operations | -44.30% | -131.15% | -37.56% | 14.26% | -49.56% |
| Capital Expenditure | 94.00% | -2,085.71% | 104.65% | 97.06% | 82.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 94.00% | -2,085.71% | 104.65% | 97.06% | 82.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -5.26% | 3.17% | 18.06% | 3.36% |
| Issuance of Common Stock | -- | -- | -- | 300.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -103.13% | -5,414.91% | 142,749.21% | -367.13% | 28,780.67% |
| Foreign Exchange rate Adjustments | 131.25% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -179.58% | -202.59% | 1,773.80% | 9.67% | 373.71% |